NABP, FDA Collaborate to Improve Compounding Pharmacy Oversight

Posted by in Boards of Pharmacy and NABP, Pharmacies and Pharmacists, State and Federal Regulatory Issues tagged with ,

Graphic showing people collaborating

In 2012, many of the people who received contaminated steroid injections produced at the New England Compounding Center had already been suffering from chronic pain. The compounded drugs were supposed to provide relief. Instead, they infected these patients with fungal meningitis, killing 64 and sickening 753.   The tragedy was a wakeup call for regulators, […]

Read More ›
Page 1 of 1